Published in J Virol on July 01, 1991
Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J Virol (1995) 2.70
Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice. J Virol (1992) 1.55
Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice. J Virol (1993) 1.39
Experimental rabies vaccines for humans. Expert Rev Vaccines (2010) 1.12
In vivo role of lymphocyte subpopulations in the control of virus excretion and mucosal antibody responses of cattle infected with rotavirus. J Virol (1993) 1.10
Fine mapping of the friend retrovirus resistance gene, Rfv3, on mouse chromosome 15. J Virol (1999) 1.10
CD8 T cells require gamma interferon to clear borna disease virus from the brain and prevent immune system-mediated neuronal damage. J Virol (2005) 0.94
CD4+ T cells are essential in overcoming experimental murine measles encephalitis. Immunology (1994) 0.93
Role of antibodies in controlling viral disease: lessons from experiments of nature and gene knockouts. J Virol (2000) 0.92
Investigating the role for IL-21 in rabies virus vaccine-induced immunity. PLoS Negl Trop Dis (2013) 0.90
Protective vaccine-induced CD4(+) T cell-independent B cell responses against rabies infection. J Virol (2012) 0.89
Development in Immunoprophylaxis against Rabies for Animals and Humans. Avicenna J Med Biotechnol (2010) 0.88
Localization of a passively transferred human recombinant monoclonal antibody to herpes simplex virus glycoprotein D to infected nerve fibers and sensory neurons in vivo. J Virol (1999) 0.88
Reinvestigating the role of IgM in rabies virus postexposure vaccination. J Virol (2013) 0.88
Neonatal deletion and selective expansion of mouse T cells by exposure to rabies virus nucleocapsid superantigen. J Exp Med (1994) 0.85
A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein. J Virol (2012) 0.85
Rabies virus neuritic paralysis: immunopathogenesis of nonfatal paralytic rabies. J Virol (1992) 0.83
B cell infection and activation by rabies virus-based vaccines. J Virol (2013) 0.82
Cross-protective and cross-reactive immune responses to recombinant vaccinia viruses expressing full-length lyssavirus glycoprotein genes. Epidemiol Infect (2007) 0.80
Survival of rabid rabbits after intrathecal immunization. Neuropathology (2014) 0.77
Suppression of measles virus expression by noncytolytic antibody in an immortalized macrophage cell line. J Virol (1995) 0.76
Role of nitric oxide in the regulation of immune responses during rabies virus infection in mice. Virusdisease (2016) 0.75
Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature (1985) 9.62
A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ (1973) 4.22
Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J Gen Virol (1987) 3.16
Immune lysis of rabies virus-infected cells. J Immunol (1968) 2.25
Rabies virus glycoprotein. II. Biological and serological characterization. Infect Immun (1977) 2.14
Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein. Proc Natl Acad Sci U S A (1987) 1.76
Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. J Immunol (1988) 1.72
Comparative study of abortive and nonabortive rabies in mice. J Infect Dis (1969) 1.62
Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies. J Gen Virol (1983) 1.50
IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells. J Immunol (1989) 1.48
The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants. Scand J Immunol (1987) 1.41
Induction of rabies virus-specific T-helper cells by synthetic peptides that carry dominant T-helper cell epitopes of the viral ribonucleoprotein. J Virol (1989) 1.27
Suppression of cell-mediated immunity by street rabies virus. J Exp Med (1977) 1.25
The role of antibody in recovery from experimental rabies. I. Effect of depletion of B and T cells. J Immunol (1978) 1.19
Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine. J Gen Virol (1978) 1.18
Immune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein. Can J Vet Res (1987) 1.16
Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. J Gen Virol (1989) 1.15
Recognition of rabies and rabies-related viruses by T cells derived from human vaccine recipients. J Virol (1988) 1.05
Vaccinia virus recombinants expressing rabiesvirus glycoprotein protect against rabies. Virus Genes (1987) 1.05
Genetic control of resistance to street rabies virus in mice. J Exp Med (1983) 1.01
Pathogenesis of street rabies virus infections in resistant and susceptible strains of mice. J Virol (1985) 0.98
Delayed-type hypersensitivity to rabies virus in mice: assay of active or passive sensitization by the footpad test. Infect Immun (1978) 0.98
Resistance to experimental autoimmune thyroiditis: L3T4+ cells as mediators of both thyroglobulin-activated and TSH-induced suppression. Clin Immunol Immunopathol (1989) 0.98
Depletion of L3T4+ and Lyt-2+ cells by rat monoclonal antibodies alters the development of adoptively transferred experimental autoimmune thyroiditis. Cell Immunol (1989) 0.93
Influence of cell type and virus upon lysis of rabies virus-infected cells by antibody and complement. Arch Virol (1981) 0.93
Rabies virus immunity in genetically selected high- and low-responder lines of mice. Infect Immun (1979) 0.92
Histoincompatibility associated with the X chromosome in mice. Transplantation (1963) 0.91
Murine susceptibility to street rabies virus is unrelated to induction of host lymphoid depletion. J Immunol (1990) 0.87
Murine T cell clones directed to rabies virus: isolation and some of their properties. J Gen Virol (1987) 0.85
Interleukin 2 increases protection against experimental rabies. Immunobiology (1988) 0.84
Interferon induced within the central nervous system during infection is inconsequential as a mechanism responsible for murine resistance to street rabies virus. J Gen Virol (1989) 0.84
Protection against rabies in mice by a cytotoxic T cell clone recognizing the glycoprotein of rabies virus. J Gen Virol (1990) 0.84
Cytotoxicity reactions against target cells infected with rabies virus. J Virol Methods (1982) 0.83
Detection of anti-rabies virus cytotoxic T lymphocytes in mice of four distinct H-2 haplotypes using target cells persistently infected with ERA rabies virus. J Virol Methods (1990) 0.79
A double determinant sandwich immunoassay for quantitation of serum monoclonal anti-I-A antibody. J Immunol Methods (1985) 0.78
Prevention of cell-to-cell spread of herpes simplex virus by leukocytes. J Exp Med (1973) 2.42
Human diploid-cell rabies vaccine: efficacy of four doses. Lancet (1996) 2.07
Comparative study of abortive and nonabortive rabies in mice. J Infect Dis (1969) 1.62
Cellular immunity to herpes simplex virus mediated by interferon. J Exp Med (1974) 1.52
Different H-2 subregions influence immunization against retrovirus and immunosuppression. Nature (1987) 1.43
Hemagglutinin antibody response of normal and Aleutian disease-affected mink to keyhole limpet hemocyanin. J Immunol (1970) 1.29
Characterization of Sri Lanka rabies virus isolates using nucleotide sequence analysis of nucleoprotein gene. Acta Virol (2001) 1.14
Rabies virus replication in primary murine bone marrow macrophages and in human and murine macrophage-like cell lines: implications for viral persistence. J Virol (1995) 1.13
Brain neutralization of rabies virus to distinguish recovered animals from previously vaccinated animals. J Immunol (1966) 1.06
Genetic control of resistance to street rabies virus in mice. J Exp Med (1983) 1.01
Immune sera and antiglycoprotein monoclonal antibodies inhibit in vitro cell-to-cell spread of pathogenic rabies viruses. J Virol (1987) 0.99
Pathogenesis of street rabies virus infections in resistant and susceptible strains of mice. J Virol (1985) 0.98
Influence of cell type and virus upon lysis of rabies virus-infected cells by antibody and complement. Arch Virol (1981) 0.93
Paralysis of street rabies virus-infected mice is dependent on T lymphocytes. J Virol (1992) 0.91
Antibody-forming cells and serum hemolysin responses of pastel and sapphire mink inoculated with Aleutian disease virus. Infect Immun (1973) 0.91
Murine susceptibility to street rabies virus is unrelated to induction of host lymphoid depletion. J Immunol (1990) 0.87
Enhanced resistance against encephalomyocarditis virus infection in mice, induced by a nonviable Mycobacterium tuberculosis oil-droplet vaccine. Infect Immun (1978) 0.84
Murine resistance to street rabies virus: genetic analysis by testing second-backcross progeny and verification of allelic resistance genes in SJL/J and CBA/J mice. J Virol (1984) 0.84
Induction of enhanced resistance against encephalomyocarditis virus infection of mice by nonviable Mycobacterium tuberculosis: mechanisms of protection. Infect Immun (1978) 0.83
Rabies viruses infect primary cultures of murine, feline, and human microglia and astrocytes. Arch Virol (1997) 0.83
Interferon response in normal and Aleutian disease virus-infected mink. J Virol (1986) 0.82
Delayed hypersensitivity in normal and aleutian disease-affected mink. Z Immunitatsforsch Exp Klin Immunol (1974) 0.82
Inhibition of vaccinia virus replication in skin of tuberculin-sensitized animals challenged with PPD. J Immunol (1976) 0.80
Mink parvoviruses and interferons: in vitro studies. J Virol (1986) 0.79
Nonspecific inhibition of encephalomyocarditis virus replication by a type II interferon released from unstimulated cells of Mycobacterium tuberculosis-sensitized mice. J Immunol (1980) 0.79
Detection of anti-rabies virus cytotoxic T lymphocytes in mice of four distinct H-2 haplotypes using target cells persistently infected with ERA rabies virus. J Virol Methods (1990) 0.79
Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection. Vaccine (1997) 0.78
A technic for multiple bleedings or intravenous inoculations of mink at prescribed intervals. Lab Anim Sci (1972) 0.77
Rabies virus isolation from a bat in Montana in midwinter. Public Health Rep (1966) 0.75
Effect of limb disability on lousiness of mice. V. Hierarchy disturbance on mutual grooming and reproductive capacities. Exp Parasitol (1970) 0.75